JANX
Janux Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.58
-0.36 ▼ -2.62%
🌙 3월 13일 7:30 PM ET (한국 3/14 08:30)
$13.45
-0.13 ▼ -0.93%
| Index | RUT | P/E | - | EPS (ttm) | -1.83 | Insider Own | 13.61% | Shs Outstand | 0.06B | Perf Week | -1.88% |
| Market Cap | 0.83B | Forward P/E | - | EPS next Y | -23.74% | Insider Trans | -0.51% | Shs Float | 0.05B | Perf Month | 3.59% |
| Enterprise Value | -0.12B | PEG | - | EPS next Q | -0.59 | Inst Own | 97.54% | Short Float | 19.02% | Perf Quarter | -12.84% |
| Income | -0.11B | P/S | 82.61 | EPS this Y | -42.67% | Inst Trans | -7.39% | Short Ratio | 6.33 | Perf Half Y | -45.94% |
| Sales | 0.01B | P/B | 0.86 | EPS next 5Y | -26.76% | ROA | -10.98% | Short Interest | 10.00M | Perf YTD | -1.59% |
| Book/sh | 15.85 | P/C | 0.85 | EPS past 3/5Y | -6.44% -62.26% | ROE | -11.48% | 52W High | -61.57% ($35.34) | Perf Year | -56.68% |
| Cash/sh | 15.89 | P/FCF | - | Sales past 3/5Y | 5.11% - | ROIC | -11.64% | 52W Low | 12.05% ($12.12) | Perf 3Y | -1.31% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -43.27% | Gross Margin | 79.71% | Volatility(W/M) | 3.9% 3.99% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | -11.83 | Sales Y/Y TTM | -5.55% | Oper. Margin | -1576.67% | ATR (14) | 0.6 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 39.04 | EPS Q/Q | -44.5% | Profit Margin | -1136.25% | RSI (14) | 46.34 | Recom | 1.38 |
| Dividend Gr. 3/5Y | - | Current Ratio | 39.04 | Sales Q/Q | - | SMA20 | -0.46% ($13.64) | Beta | 2.85 | Target Price | $50.71 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | -0.91% ($13.7) | Rel Volume | 0.69 | Prev Close | $13.94 |
| Employees | 109 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 18.37% -100% | SMA200 | -36.74% ($21.47) | Avg Volume(3M) | 1.58M | Price | $13.58 |
| IPO | 2021/6/11 | Option/Short | Yes/Yes | Trades | 15786 | Volume | 1,084,125 | Change | -2.62% |
뉴스 로딩 중...